Title | Inhibition of CCR8 attenuates Ang Ⅱ-induced vascular smooth muscle cell injury by suppressing the MAPK/NF-κB pathway |
Author | |
Corresponding Author | Xu,Jinfeng |
Publication Years | 2022-09-01
|
DOI | |
Source Title | |
ISSN | 2008-3866
|
EISSN | 2008-3874
|
Volume | 26Issue:9Pages:1097-1103 |
Abstract | Objective(s): Hyperinsulinemia, secondary to insulin resistance, may lead to vascular smooth muscle cell dysfunction. In the present research, we aimed to investigate the effect of Chemokine receptor 8 (CCR8) on angiotensin II (Ang II)-induced dysfunction of vascular smooth muscle cells (VSMCs) and to explore the underlying molecular mechanism. Materials and Methods: The expression of CCR8 was analyzed in diabetics and normal people by RT-PCR and ELISA. CCK-8 assay and transwell were used to explore cell proliferation and migration, and ELISA was used to measure the content of IL-6 and TNF-α. Reactive oxygen species (ROS) kit was employed to measure ROS generation. Results: The results revealed that CCR8 was highly expressed in diabetics and Ang Ⅱ-induced VSMCs. Further studies found that interfering with the expression of CCR8 significantly reduced the production of ROS and the levels of inflammatory factors in AngⅡ-induced VSMCs. Interfering with CCR8 increased the glucose uptake induced by AngⅡ+IR. More importantly, inhibition of CCR8 alleviated Ang II-induced dysfunction of VSMCs. Inhibition of CCR8 inactivated the MAPK/NF-κB signaling pathway. Conclusion: Inhibition of CCR8 attenuates Ang II-induced VSMCs injury by inhibiting the MAPK/NFκB pathway. CCR8 may be a new biomarker related to hypertension and insulin resistance and is a new target for the treatment of human cardiovascular diseases. |
Keywords | |
URL | [Source Record] |
Language | English
|
SUSTech Authorship | First
; Corresponding
|
Scopus EID | 2-s2.0-85138633140
|
Data Source | Scopus
|
Citation statistics |
Cited Times [WOS]:0
|
Document Type | Journal Article |
Identifier | http://kc.sustech.edu.cn/handle/2SGJ60CL/402715 |
Department | Shenzhen People's Hospital |
Affiliation | 1.The Second Clinical Medical College,Jinan University,Department of Ultrasound,The First Affiliated Hospital,Southern University of Science and Technology,Department of Ultrasound,Shenzhen People’s Hospital,Shenzhen,Guangdong,518020,China 2. |
First Author Affilication | Shenzhen People's Hospital |
Corresponding Author Affilication | Shenzhen People's Hospital |
First Author's First Affilication | Shenzhen People's Hospital |
Recommended Citation GB/T 7714 |
Liao,Lisi,Song,Di,Shi,Bobo,et al. Inhibition of CCR8 attenuates Ang Ⅱ-induced vascular smooth muscle cell injury by suppressing the MAPK/NF-κB pathway[J]. Iranian Journal of Basic Medical Sciences,2022,26(9):1097-1103.
|
APA |
Liao,Lisi.,Song,Di.,Shi,Bobo.,Chen,Ming.,Wu,Linghu.,...&Dong,Fajin.(2022).Inhibition of CCR8 attenuates Ang Ⅱ-induced vascular smooth muscle cell injury by suppressing the MAPK/NF-κB pathway.Iranian Journal of Basic Medical Sciences,26(9),1097-1103.
|
MLA |
Liao,Lisi,et al."Inhibition of CCR8 attenuates Ang Ⅱ-induced vascular smooth muscle cell injury by suppressing the MAPK/NF-κB pathway".Iranian Journal of Basic Medical Sciences 26.9(2022):1097-1103.
|
Files in This Item: | There are no files associated with this item. |
|
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment